Elizabeth Yurth, M.D.

speaker
572 appearances 1 recordings 1 series first heard Feb 2026 last heard 8 Feb

Elizabeth Yurth, M.D.’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
1 · Feb OctJan 26AprJulnow

Recordings per month over the last 12 months — 1 in all, peaking in Feb 2026 with 1.

Appearances

newest first · ▶ plays the moment
because I don't piss off a lot of people, because even a lot of doctors use research peptides, right?
So peptides either come from compounding pharmacies, which are, the pharmacy is regulated by the FDA.
So even though these are not FDA approved drugs, the pharmacy is regulated by the FDA.
They get inspections, they have to follow certain standards, and they have to go through a much more rigorous testing process for anything that they're handing out.
So, me as a physician, if I prescribe something, I rely on the pharmacy that this is going to be sterile, it's not going to have things in it that shouldn't be in it, it's going to have in it what it should have in it, right?
And that's my kind of protection in a sense, right?
I'm getting stuff that I know the pharmacy has to stand behind.
So, if something's wrong with that peptide, the pharmacy is really the problem.
And so, you work with legitimate pharmacies that are well-tested, that we know well.
So, we work with seven or eight different pharmacies across the US to get the different peptides we want.
Now, what's the difference?
Because people who talk about the research peptides are going to say, well, it's the same compounds.
They're getting the same compounds from the same place.
And to some degree, that's true.
The difference is that when you look at a research-grade peptide, they don't have to.
The facility does not have to be tested.
There's nobody coming in.
So they can give you a certificate of analysis, right?
So they give you what's called a COA.
Everybody's like, I have the same COA.
Showing 141–160 of 572 · page 8 of 29 ← Previous Next →